Equibles does not estimate personal net worth.
Get an email with a short summary when Relay Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get RLAY alertsPete Wehmer has spoken on 4 investor events across 1 company, most recently for Relay Therapeutics, Inc. on September 8, 2026. Relay Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Relay Therapeutics, Inc. includes Thomas Catinazzo (CFO), Brian R. Adams (General Counsel), Claire Mazumdar (Board Member) and 4 others.
“So over the next 12 months, you know, coming off a very exciting first nine months of the year for us, made a number of disclosures across both vascular anomalies and breast cancer.”
“We are very excited to share our initial vascular anomalies data with you today. you can access the press release from today the slides we are reviewing and replay of this call by going to the investor relations section of our website as a reminder during this call we will make certain statements that are considered…”
“We're excited to share our Frontline Breast Cancer Update with you today. You can access the press release from today, the slides we are reviewing, and a replay of this call by going to the Investor Relations section of our website.”
“We're excited to share our Frontline Breast Cancer Update with you today. You can access the press release from today, the slides we are reviewing, and a replay of this call by going to the Investor Relations section of our website.”
Transcript header (unverified)
Biotechnology · Healthcare
